We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$62.6M
Cap. Flow
-$68.5M
Cap. Flow %
-6%
Top 10 Hldgs %
20.56%
Holding
206
New
27
Increased
44
Reduced
47
Closed
29

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$19M
2
AXSM icon
Axsome Therapeutics
AXSM
+$12M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.2M
4
CHX
ChampionX
CHX
+$11M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.5M

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$15.9M
2
UTHR icon
United Therapeutics
UTHR
+$14.3M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.4M
4
STAA icon
STAAR Surgical
STAA
+$11.7M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.14%
2 Technology 14.06%
3 Industrials 9.62%
4 Energy 8.22%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGCW
151
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$10.9K ﹤0.01%
27,148
– –
BX icon
152
Blackstone
BX
$110B
– –
-67,990
Closed -$5.69M
CRM icon
153
Salesforce
CRM
$158B
– –
-1,405
Closed -$202K
DOCN icon
154
DigitalOcean
DOCN
$14.6B
– –
-23,815
Closed -$861K
FIVN icon
155
FIVE9
FIVN
$2.54B
– –
-106,957
Closed -$8.02M
FRPT icon
156
Freshpet
FRPT
$3.22B
– –
-68,991
Closed -$3.46M
GO icon
157
Grocery Outlet
GO
$980M
– –
-106,201
Closed -$3.54M
GOSS icon
158
Gossamer Bio
GOSS
$87M
– –
-469,317
Closed -$5.62M
GTLS
159
DELISTED
Chart Industries
GTLS
– –
-32,131
Closed -$5.92M
IGV icon
160
iShares Expanded Tech-Software Sector ETF
IGV
$14.7B
– –
-31,195
Closed -$1.56M
LRN icon
161
Stride
LRN
$3.43B
– –
-68,340
Closed -$2.87M
LULU icon
162
lululemon athletica
LULU
$14.6B
– –
-1,595
Closed -$446K
MAT icon
163
Mattel
MAT
$4.23B
– –
-117,737
Closed -$2.23M
NEE icon
164
NextEra Energy
NEE
$177B
– –
-5,048
Closed -$396K
PBH icon
165
Prestige Consumer Healthcare
PBH
$2.6B
– –
-49,385
Closed -$2.46M
RLMD icon
166
Relmada Therapeutics
RLMD
$527M
– –
-243,385
Closed -$9.01M
STAA icon
167
STAAR Surgical
STAA
$1.21B
– –
-166,316
Closed -$11.7M
SWTX
168
DELISTED
SpringWorks Therapeutics
SWTX
– –
-557,175
Closed -$15.9M
TAP icon
169
Molson Coors Class B
TAP
$8.09B
– –
-73,000
Closed -$3.5M
TGT icon
170
Target
TGT
$68B
– –
-9,631
Closed -$1.43M
TIL icon
171
Instil Bio
TIL
$50.3M
– –
-44,869
Closed -$4.34M
TWST icon
172
Twist Bioscience
TWST
$7.25B
– –
-320,168
Closed -$11.3M
UTHR icon
173
United Therapeutics
UTHR
$23.1B
– –
-68,190
Closed -$14.3M
VRRM icon
174
Verra Mobility
VRRM
$744M
– –
-715,520
Closed -$11M
ZNTL icon
175
Zentalis Pharmaceuticals
ZNTL
$302M
– –
-158,704
Closed -$3.44M
4 5 6
7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Nicholas Investment Partners held 206 positions worth $1.14B, up 5.8% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $68.5M in Q4 2022, closing 29 positions and reducing 47 holdings. Its most notable exit was SpringWorks Therapeutics, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Lantheus worth $15.7M.

  • Nicholas Investment Partners's largest Q4 2022 buy was Lantheus: 308,295 shares worth $15.7M.
  • Nicholas Investment Partners added most to Wintrust Financial in Q4 2022, an estimated $5.83M increase.
  • Nicholas Investment Partners's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $13.4M.
  • Nicholas Investment Partners fully exited SpringWorks Therapeutics in Q4 2022, selling an estimated $15.9M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2022.
  • Nicholas Investment Partners opened 27 new positions and closed 29 in Q4 2022.
  • Nicholas Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.